List of insiders holdings for MOMENTA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| NOVARTIS AG 10% Owner | 2016-08-30 17:05:20 | 3,315,366 0 | 3,315,366 | Form 13D |
| POLARIS VENTURE MANAGEMENT CO III LLC POLARIS VENTURE PARTNERS III LP POLARIS VENTURE PARTNERS FOUNDERS FUND III LP POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP Arnold Stephen D Flint Jonathan A MCGUIRE TERRANCE SPOON ALAN G 10% Owner | 2006-02-14 11:28:29 | 1,816,749 0 | 1,816,749 | Form 13G |
| MVM International Life Sciences Fund No 1 L P 10% Owner | 2007-01-31 15:34:04 | 1,369,696 0 | 1,369,696 | Form 13G |
| Reeders Stephen T Director | 2008-03-31 20:07:17 | 5429 947,576 | 953,005 | Form 4 |
| LANGER ROBERT Director | 2008-08-11 16:59:08 | 950,022 0 | 950,022 | Form 4 |
| Crane Alan L Former Director Director | 2010-05-24 17:40:58 | 741,720 0 | 741,720 | Form 4/A |
| Brugger Stephen B Chief Operating Officer | 2010-11-01 17:57:13 | 674,376 0 | 674,376 | Form 4 |
| Kaundinya Ganesh Venkataraman COO & CSO | 2018-08-23 16:22:06 | 495,145 0 | 495,145 | Form 4 |
| Sasisekharan Ram Director | 2010-07-27 16:50:11 | 340,274 0 | 340,274 | Form 4 |
| ZABRISKIE JOHN L Director | 2004-07-01 21:33:30 | 251,998 0 | 251,998 | Form 4 |
| HUTT PETER BARTON Director | 2014-09-15 15:25:33 | 203,725 0 | 203,725 | Form 4 |
| CLARKE JOHN K Director | 2015-06-11 11:55:08 | 176,350 0 | 176,350 | Form 4 |
| Leicher Bruce SVP & General Counsel | 2018-08-23 16:21:32 | 171,801 0 | 171,801 | Form 4 |
| TYLER JOSEPH E Vice President, Manufacturing | 2004-07-13 15:30:59 | 163,200 0 | 163,200 | Form 3 |
| Bishop John E Senior VP, Pharmaceutical Scie | 2016-05-23 12:40:04 | 157,253 0 | 157,253 | Form 4 |
| Roach James M. Senior VP, Development and Chi | 2016-11-23 10:41:14 | 155,381 0 | 155,381 | Form 4 |
| Shea Richard P SVP, CFO | 2016-12-16 15:41:04 | 119,906 0 | 119,906 | Form 4 |
| Storer Scott M SVP, CFO | 2018-02-14 18:15:12 | 99,783 0 | 99,783 | Form 4 |
| Barrett Peter Director | 2008-06-09 16:25:45 | 96,000 0 | 96,000 | Form 4 |
| SULAT JAMES R Director | 2019-06-21 16:14:04 | 79,090 0 | 79,090 | Form 4 |
| Ottmer Matthew P. Chief Operating Officer | 2017-02-09 16:52:30 | 72,000 0 | 72,000 | Form 4 |
| Whoriskey Susan K V.P., Lic. & Bus. Dev. | 2007-05-25 16:16:47 | 65,500 0 | 65,500 | Form 4 |
| Lisa Carron Shmerling V.P., Legal Affairs | 2007-03-22 16:52:51 | 63,250 0 | 63,250 | Form 4 |
| Westphal Christoph H Director | 2005-05-27 13:31:58 | 57,600 0 | 57,600 | Form 4 |
| Koestler Thomas P Director | 2019-06-21 16:14:47 | 40,590 0 | 40,590 | Form 4 |
| Franken Michael President, Biosimilars Busines | 2015-12-14 11:16:08 | 37,968 0 | 37,968 | Form 4 |
| Fishman Corey N. Director | 2019-06-21 16:16:28 | 35,090 0 | 35,090 | Form 4 |
| GOLDENHEIM PAUL D Director | 2006-05-31 18:07:11 | 34,562 0 | 34,562 | Form 4 |
| Fanucci Marsha Director | 2016-06-27 14:31:28 | 25,500 0 | 25,500 | Form 4 |
| Shapiro Bennett M Director | 2016-06-08 15:55:37 | 24,834 0 | 24,834 | Form 4 |
| ROBERTSON MICHELLE Chief Financial Officer | 2019-10-29 20:57:54 | 6813 0 | 6813 | Form 4 |
| KWON YOUNG Chief Financial & Bus. Officer | 2020-10-01 17:05:24 | 0 0 | 0 | Form 4 |
| Stoner Elizabeth Director | 2020-10-01 17:18:25 | 0 0 | 0 | Form 4 |
| Gutierrez-Ramos Jose-Carlos Director | 2020-10-01 17:17:07 | 0 0 | 0 | Form 4 |
| GROGAN DONNA ROY Director | 2020-10-01 17:15:51 | 0 0 | 0 | Form 4 |
| GILMAN STEVEN C Director | 2020-10-01 17:14:42 | 0 0 | 0 | Form 4 |
| GEMAYEL GEORGES Director | 2020-10-01 17:12:58 | 0 0 | 0 | Form 4 |
| DOWNEY BRUCE Director | 2020-10-01 17:10:44 | 0 0 | 0 | Form 4 |
| Barlow Jane F Director | 2020-10-01 17:08:34 | 0 0 | 0 | Form 4 |
| Manning Anthony M. Chief Scientific Officer | 2020-10-01 17:07:30 | 0 0 | 0 | Form 4 |
| ATLAS VENTURE FUND V LP ATLAS VENTURE PARALLEL FUND V-A C V ATLAS VENTURE PARALLEL FUND V-B C V ATLAS VENTURE ENTREPRENEURS FUND V LP ATLAS VENTURE FUND VI LP Atlas Venture Fund VI GmbH & Co KG ATLAS VENTURE ENTREPRENEURS FUND VI LP ATLAS VENTURE ASSOCIATES V LP Atlas Venture Associates VI L.P. 10% Owner | 2009-02-13 14:32:46 | 0 0 | 0 | Form 13G |
| FIER IAN Chief Mfg and Program Officer | 2020-10-01 17:03:22 | 0 0 | 0 | Form 4 |
| Cieplinska Agnieszka Chief Accounting Officer (PAO) | 2020-10-01 17:01:45 | 0 0 | 0 | Form 4 |
| Carvajal Alejandra Chief Legal Officer | 2020-10-01 17:00:06 | 0 0 | 0 | Form 4 |
| BELTRAMELLO JO ANN Chief HR and Inf. Officer | 2020-10-01 16:58:04 | 0 0 | 0 | Form 4 |
| Arroyo Santiago SVP, Chief Medical Officer | 2020-10-01 16:56:35 | 0 0 | 0 | Form 4 |
| WHEELER CRAIG A President & CEO | 2020-10-01 16:55:17 | 0 0 | 0 | Form 4 |
| ATLAS VENTURE FUND V LP ATLAS VENTURE ENTREPRENEURS FUND V LP ATLAS VENTURE ENTREPRENEURS FUND VI LP Atlas Venture Fund VI GmbH & Co KG ATLAS VENTURE FUND VI LP ATLAS VENTURE PARALLEL FUND V-A C V ATLAS VENTURE PARALLEL FUND V-B C V ATLAS VENTURE ASSOCIATES V LP Atlas Venture Associates VI Inc 10% Owner | 2009-02-13 14:32:46 | 0 0 | 0 | Form 13G |